ICMR & Panacea Biotec complete enrollment for India's first indigenous dengue vaccine phase 3 study
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
Heart failure affects an estimated 64.3 million people worldwide
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
Subscribe To Our Newsletter & Stay Updated